Microbial ecology of the cystic fibrosis lung.
暂无分享,去创建一个
[1] D. Pritchard,et al. Differential Immune Modulatory Activity of Pseudomonas aeruginosa Quorum-Sensing Signal Molecules , 2004, Infection and Immunity.
[2] David A. D'Argenio,et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[3] N. Høiby,et al. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. , 2004, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[4] N. Busquets,et al. Microorganismos patógenos aislados en muestras respiratorias de niños con fibrosis quística , 2005 .
[5] Gabriel Hessel,et al. Fibrose cística em um centro de referência no Brasil: características clínicas e laboratoriais de 104 pacientes e sua associação com o genótipo e a gravidade da doença , 2004 .
[6] M. M. van der Zalm,et al. Viral respiratory infections in cystic fibrosis , 2005, Journal of Cystic Fibrosis.
[7] U. Römling,et al. Impact of large chromosomal inversions on the adaptation and evolution of Pseudomonas aeruginosa chronically colonizing cystic fibrosis lungs , 2002, Molecular microbiology.
[8] J. Marks,et al. Siderophore Presence in Sputa of Cystic Fibrosis Patients , 1992, Infection and immunity.
[9] P. Lebecque,et al. Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis. , 2006, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[10] A. Birch‐Andersen,et al. Morphology Of Pseudomonas aeruginosa phages from the sputum of cystic fibrosis patients and from the phage typing set , 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[11] M. A. Santana,et al. Prevalence of pathogens in cystic fibrosis patients in Bahia, Brazil. , 2003, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[12] J. Carlin,et al. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis , 1996, Pediatric pulmonology.
[13] D. Smith,et al. Regional microbiology of the cystic fibrosis lung: a post-mortem study in adults. , 1998, The Journal of infection.
[14] N. Høiby,et al. EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA INFECTION IN PATIENTS TREATED AT A CYSTIC FIBROSIS CENTRE , 1980, Acta pathologica et microbiologica Scandinavica. Section B, Microbiology.
[15] R. Stern,et al. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis , 1990, The Lancet.
[16] G. Rogers,et al. Characterization of Bacterial Community Diversity in Cystic Fibrosis Lung Infections by Use of 16S Ribosomal DNA Terminal Restriction Fragment Length Polymorphism Profiling , 2004, Journal of Clinical Microbiology.
[17] A. O'Brien-Ladner,et al. Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis. , 1999, American journal of respiratory and critical care medicine.
[18] Richard C Boucher,et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.
[19] A. Buckling,et al. Hypermutability Impedes Cooperation in Pathogenic Bacteria , 2005, Current Biology.
[20] G. Haase,et al. Long‐term fungal cultures from sputum of patients with cystic fibrosis , 1991, Mycoses.
[21] E. Mahenthiralingam,et al. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis , 1994, Infection and immunity.
[22] B. Guéry,et al. Quorum sensing : une nouvelle cible thérapeutique pour Pseudomonas aeruginosa , 2006 .
[23] N. Høiby,et al. Eradication of early Pseudomonas aeruginosa infection. , 2005, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[24] N. Høiby,et al. RESPIRATORY INFECTIONS IN CYSTIC FIBROSIS PATIENTS CAUSED BY VIRUS, CHLAMYDIA AND MYCOPLASMA–POSSIBLE SYNERGISM WITH PSEUDOMONAS AERUGINOSA , 1981, Acta paediatrica Scandinavica.
[25] William E Bentley,et al. Microarray analysis of Pseudomonas aeruginosa reveals induction of pyocin genes in response to hydrogen peroxide , 2005, BMC Genomics.
[26] Leo Eberl,et al. Quorum sensing in the genus Burkholderia. , 2006, International journal of medical microbiology : IJMM.
[27] J. Villena,et al. Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. , 2005, The Journal of nutrition.
[28] J. Carlin,et al. Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis. , 2001, The European respiratory journal.
[29] A. Buckling,et al. Interference competition and parasite virulence , 2004, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[30] F. Hoerr,et al. Use of Bacteriophages in Combination with Competitive Exclusion to Reduce Salmonella from Infected Chickens , 2005, Avian diseases.
[31] Y. Michel-Briand,et al. The pyocins of Pseudomonas aeruginosa. , 2002, Biochimie.
[32] M. Whiteley,et al. Staphylococcus aureus Serves as an Iron Source for Pseudomonas aeruginosa during In Vivo Coculture , 2005, Journal of bacteriology.
[33] A. Griffin,et al. Cooperation and competition in pathogenic bacteria , 2004, Nature.
[34] A. Dalton,et al. Pulmonary infection in mild variant cystic fibrosis: implications for care. , 2006, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[35] S. Molin,et al. N-acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. , 2001, Microbiology.
[36] R. Geffers,et al. A Cystic Fibrosis Epidemic Strain of Pseudomonas aeruginosa Displays Enhanced Virulence and Antimicrobial Resistance , 2005, Journal of bacteriology.
[37] A. Griffin,et al. Social evolution theory for microorganisms , 2006, Nature Reviews Microbiology.
[38] S. El-Shafie,et al. Microbiological identification in cystic fibrosis patients with CFTR I1234V mutation. , 2004, Journal of tropical pediatrics.
[39] G. O’Toole,et al. Susceptibility of Biofilms to Bdellovibrio bacteriovorus Attack , 2005, Applied and Environmental Microbiology.
[40] G. Perdigón,et al. Effect of Lactobacillus casei and yogurt administration on prevention of Pseudomonas aeruginosa infection in young mice. , 2001, Journal of food protection.
[41] J. Ribeiro,et al. [Cystic fibrosis at a Brazilian center of excellence: clinical and laboratory characteristics of 104 patients and their association with genotype and disease severity]. , 2004, Jornal de Pediatria.
[42] B. Tümmler,et al. Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. , 2003, Journal of medical microbiology.
[43] B. Tümmler,et al. Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations , 2001, Archives of Microbiology.
[44] N. Høiby,et al. Occurrence of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Patients Is Associated with the Oxidative Stress Caused by Chronic Lung Inflammation , 2005, Antimicrobial Agents and Chemotherapy.
[45] L. Saiman. Microbiology of early CF lung disease. , 2004, Paediatric respiratory reviews.
[46] P. Vandamme,et al. Characterization of Unusual Bacteria Isolated from Respiratory Secretions of Cystic Fibrosis Patients and Description of Inquilinus limosus gen. nov., sp. nov , 2002, Journal of Clinical Microbiology.
[47] J. Govan. In vivo significance of bacteriocins and bacteriocin receptors. , 1986, Scandinavian journal of infectious diseases. Supplementum.
[48] Pradeep K. Singh,et al. Cystic Fibrosis Sputum Supports Growth and Cues Key Aspects of Pseudomonas aeruginosa Physiology , 2005, Journal of bacteriology.
[49] J. Elborn,et al. Microbial ecology of the cystic fibrosis lung: does microflora type influence microbial loading? , 2005, British journal of biomedical science.
[50] V. Raia,et al. BMC Infectious Diseases BioMed Central Research article , 2006 .
[51] Gerald B. Pier,et al. Lung Infections Associated with Cystic Fibrosis , 2002, Clinical Microbiology Reviews.
[52] N. Høiby. Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis. , 2009, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.
[53] J. Emerson,et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[54] J. Carlin,et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. , 2001, The Journal of pediatrics.
[55] H. Ackermann,et al. Prevalence and Clinical Significance of Staphylococcus aureus Small-Colony Variants in Cystic Fibrosis Lung Disease , 2006, Journal of Clinical Microbiology.
[56] M. Surette,et al. Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication , 2003, Molecular microbiology.